Return to homeostasis: downregulation of NF-κB responses (original) (raw)

• Grivennikov, S.I. & Karin, M. Inflammation and oncogenesis: a vicious connection. Curr. Opin. Genet. Dev. 20, 65–71 (2010).
  CAS PubMed Google Scholar
• Lawrence, T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 1, a001651 (2009).
  PubMed PubMed Central Google Scholar
• Staudt, L.M. Oncogenic activation of NF-κB. Cold Spring Harb. Perspect. Biol. 2, a000109 (2010).
  PubMed PubMed Central Google Scholar
• Hayden, M.S. & Ghosh, S. Shared principles in NF-κB signaling. Cell 132, 344–362 (2008).
  CAS PubMed Google Scholar
• Vallabhapurapu, S. & Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693–733 (2009).
  CAS PubMed Google Scholar
• Whiteside, S.T., Epinat, J.C., Rice, N.R. & Israel, A. IκB epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16, 1413–1426 (1997).
  CAS PubMed PubMed Central Google Scholar
• Hoffmann, A., Levchenko, A., Scott, M.L. & Baltimore, D. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298, 1241–1245 (2002).
  CAS PubMed Google Scholar
• Sun, S.C., Ganchi, P.A., Ballard, D.W. & Greene, W.C. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259, 1912–1915 (1993).
  CAS PubMed Google Scholar
• Le Bail, O., Schmidt-Ullrich, R. & Israel, A. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12, 5043–5049 (1993).
  CAS PubMed PubMed Central Google Scholar
• Kearns, J.D., Basak, S., Werner, S.L., Huang, C.S. & Hoffmann, A. IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression. J. Cell Biol. 173, 659–664 (2006).
  CAS PubMed PubMed Central Google Scholar
• Arenzana-Seisdedos, F. et al. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15, 2689–2696 (1995).
  CAS PubMed PubMed Central Google Scholar
• Rao, P. et al. IκBβ acts to inhibit and activate gene expression during the inflammatory response. Nature 466, 1115–1119 (2010).
  CAS PubMed PubMed Central Google Scholar
• Scheibel, M. et al. IκBβ is an essential co-activator for LPS-induced IL-1β transcription in vivo. J. Exp. Med. 207, 2621–2630 (2010).
  CAS PubMed PubMed Central Google Scholar
• Tam, W.F. & Sen, R. IκB family members function by different mechanisms. J. Biol. Chem. 276, 7701–7704 (2001).
  CAS PubMed Google Scholar
• Chen, L., Fischle, W., Verdin, E. & Greene, W.C. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293, 1653–1657 (2001).
  CAS Google Scholar
• Mahoney, D.J. et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl. Acad. Sci. USA 105, 11778–11783 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ea, C.K., Deng, L., Xia, Z.P., Pineda, G. & Chen, Z.J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245–257 (2006).
  CAS PubMed Google Scholar
• Wu, C.J., Conze, D.B., Li, T., Srinivasula, S.M. & Ashwell, J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell Biol. [corrected] 8, 398–406 (2006).
  CAS PubMed Google Scholar
• Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098–1109 (2009).
  CAS PubMed Google Scholar
• Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384 (2010).
  CAS PubMed Google Scholar
• Rawlings, D.J., Sommer, K. & Moreno-Garcia, M.E. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6, 799–812 (2006).
  CAS PubMed Google Scholar
• Wertz, I.E. & Dixit, V.M. Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2, a003350 (2010).
  PubMed PubMed Central Google Scholar
• Lee, E.G. et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289, 2350–2354 (2000).
  CAS PubMed PubMed Central Google Scholar
• Wertz, I.E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694–699 (2004).
  CAS PubMed Google Scholar
• Hymowitz, S.G. & Wertz, I.E. A20: from ubiquitin editing to tumour suppression. Nat. Rev. Cancer 10, 332–341 (2010).
  CAS PubMed Google Scholar
• Boone, D.L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052–1060 (2004).
  CAS PubMed Google Scholar
• Mauro, C. et al. ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J. Biol. Chem. 281, 18482–18488 (2006).
  CAS PubMed Google Scholar
• Hitotsumatsu, O. et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28, 381–390 (2008).
  CAS PubMed PubMed Central Google Scholar
• Duwel, M. et al. A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains. J. Immunol. 182, 7718–7728 (2009).
  PubMed Google Scholar
• Iha, H. et al. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-κB activation. EMBO J. 27, 629–641 (2008).
  CAS PubMed PubMed Central Google Scholar
• Shembade, N. et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9, 254–262 (2008).
  CAS PubMed Google Scholar
• Scharschmidt, E., Wegener, E., Heissmeyer, V., Rao, A. & Krappmann, D. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-κB signaling. Mol. Cell. Biol. 24, 3860–3873 (2004).
  CAS PubMed PubMed Central Google Scholar
• Wagner, S. et al. Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins. Oncogene 27, 3739–3745 (2008).
  CAS PubMed Google Scholar
• Enesa, K. et al. NF-κB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 283, 7036–7045 (2008).
  CAS PubMed Google Scholar
• Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801–805 (2003).
  CAS PubMed Google Scholar
• Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424, 793–796 (2003).
  CAS PubMed Google Scholar
• Sun, S.C. CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ. 17, 25–34 (2010).
  CAS PubMed Google Scholar
• Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A. & Fassler, R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125, 665–677 (2006).
  CAS PubMed Google Scholar
• Reiley, W., Zhang, M., Wu, X., Granger, E. & Sun, S.C. Regulation of the deubiquitinating enzyme CYLD by IκB kinase γ-dependent phosphorylation. Mol. Cell. Biol. 25, 3886–3895 (2005).
  CAS PubMed PubMed Central Google Scholar
• Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263–268 (2003).
  PubMed PubMed Central Google Scholar
• Janssens, S., Burns, K., Vercammen, E., Tschopp, J. & Beyaert, R. MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett. 548, 103–107 (2003).
  CAS PubMed Google Scholar
• Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191–202 (2002).
  CAS PubMed Google Scholar
• Escoll, P. et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 311, 465–472 (2003).
  CAS PubMed Google Scholar
• van 't Veer, C. et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179, 7110–7120 (2007).
  CAS PubMed Google Scholar
• Carty, M. et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7, 1074–1081 (2006).
  CAS PubMed Google Scholar
• Wegener, E. et al. Essential role for IκB kinase β in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23, 13–23 (2006).
  CAS PubMed Google Scholar
• Lobry, C., Lopez, T., Israel, A. & Weil, R. Negative feedback loop in T cell activation through IκB kinase-induced phosphorylation and degradation of Bcl10. Proc. Natl. Acad. Sci. USA 104, 908–913 (2007).
  CAS PubMed PubMed Central Google Scholar
• Bidere, N. et al. Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival. Nature 458, 92–96 (2009).
  CAS PubMed Google Scholar
• Liu, B. et al. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 5, 891–898 (2004).
  CAS PubMed Google Scholar
• Liu, B. et al. Negative regulation of NF-κB signaling by PIAS1. Mol. Cell. Biol. 25, 1113–1123 (2005).
  CAS PubMed PubMed Central Google Scholar
• Tahk, S. et al. Control of specificity and magnitude of NF-κB and STAT1-mediated gene activation through PIASy and PIAS1 cooperation. Proc. Natl. Acad. Sci. USA 104, 11643–11648 (2007).
  CAS PubMed PubMed Central Google Scholar
• Liu, B. et al. Proinflammatory stimuli induce IKKα-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 129, 903–914 (2007).
  CAS PubMed Google Scholar
• Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. & Karin, M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138–1143 (2005).
  CAS PubMed Google Scholar
• Li, Q. et al. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1). Proc. Natl. Acad. Sci. USA 102, 12425–12430 (2005).
  CAS PubMed PubMed Central Google Scholar
• Natoli, G. & Chiocca, S. Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation. Sci. Signal. 1, pe1 (2008).
  PubMed Google Scholar
• Tanaka, T., Grusby, M.J. & Kaisho, T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8, 584–591 (2007).
  CAS PubMed Google Scholar
• Maine, G.N., Mao, X., Komarck, C.M. & Burstein, E. COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. EMBO J. 26, 436–447 (2007).
  CAS PubMed Google Scholar
• Kinjyo, I. et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583–591 (2002).
  CAS PubMed Google Scholar
• Yang, X.D. et al. Negative regulation of NF-κB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J. 28, 1055–1066 (2009).
  CAS PubMed PubMed Central Google Scholar
• Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κ B signaling pathway. Science 293, 1495–1499 (2001).
  CAS PubMed Google Scholar
• Xiao, G., Harhaj, E.W. & Sun, S.C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401–409 (2001).
  CAS PubMed Google Scholar
• Basak, S. et al. A fourth IκB protein within the NF-κB signaling module. Cell 128, 369–381 (2007).
  CAS PubMed PubMed Central Google Scholar
• Liao, G., Zhang, M., Harhaj, E.W. & Sun, S.C. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243–26250 (2004).
  CAS PubMed Google Scholar
• Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669–681 (2007).
  CAS PubMed Google Scholar
• Zarnegar, B.J. et al. Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371–1378 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yeh, W.C. et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715–725 (1997).
  CAS PubMed Google Scholar
• He, J.Q. et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J. Exp. Med. 203, 2413–2418 (2006).
  CAS PubMed PubMed Central Google Scholar
• Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364–1370 (2008).
  CAS PubMed PubMed Central Google Scholar
• Razani, B. et al. Negative feedback in noncanonical NF-κB signaling modulates NIK stability through IKKα-mediated phosphorylation. Sci. Signal. 3, ra41 (2010).
  PubMed PubMed Central Google Scholar
• Oeckinghaus, A. & Ghosh, S. The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1, a000034 (2009).
  PubMed PubMed Central Google Scholar
• Baltimore, D., Boldin, M.P., O'Connell, R.M., Rao, D.S. & Taganov, K.D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9, 839–845 (2008).
  CAS PubMed Google Scholar
• O'Neill, L.A., Sheedy, F.J. & McCoy, C.E. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11, 163–175 (2011).
  CAS PubMed Google Scholar
• Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481–12486 (2006).
  CAS PubMed PubMed Central Google Scholar
• Ceppi, M. et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 106, 2735–2740 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tang, B. et al. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of _Helicobacter pylori_-induced inflammation. FEBS Lett. 584, 1481–1486 (2010).
  CAS PubMed Google Scholar
• Jungnickel, B. et al. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J. Exp. Med. 191, 395–402 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bredel, M. et al. NFKBIA deletion in glioblastomas. N. Engl. J. Med. 364, 627–637 (2011).
  CAS PubMed Google Scholar
• Kato, M. et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 459, 712–716 (2009).
  CAS PubMed Google Scholar
• Compagno, M. et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature 459, 717–721 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ferch, U. et al. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 206, 2313–2320 (2009).
  CAS PubMed PubMed Central Google Scholar
• Musone, S.L. et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat. Genet. 40, 1062–1064 (2008).
  CAS PubMed PubMed Central Google Scholar
• Plenge, R.M. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39, 1477–1482 (2007).
  CAS PubMed PubMed Central Google Scholar
• Nair, R.P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41, 199–204 (2009).
  CAS PubMed PubMed Central Google Scholar
• Balaci, L. et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80, 1103–1114 (2007).
  CAS PubMed PubMed Central Google Scholar
• Keats, J.J. et al. Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell 12, 131–144 (2007).
  CAS PubMed PubMed Central Google Scholar
• Annunziata, C.M. et al. Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115–130 (2007).
  CAS PubMed PubMed Central Google Scholar
• Rosebeck, S. et al. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-κB activation. Science 331, 468–472 (2011).
  CAS PubMed PubMed Central Google Scholar